Disrupting RA with the Decisiveness of DNA
Crescendo wanted to increase adoption of its test for Rheumatoid Arthritis levels. The challenge was getting rheumatologists to even consider biological science in their decision-making. I co-led the design of a new report for HCPs and patients that positions bio data as an essential part of RA drug therapy plans.
Year:
2013
Client:
Crescendo Bioscience
Role:
Strategy, Design
Process
Final Design
